Cargando…

Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?

Innate immunity is the first line of the host immune system to fight against infections. Natural killer cells are the innate immunity lymphocytes responsible for fighting against virus-infected and cancerous cells. They have various mechanisms to suppress viral infections. On the other hand, viruses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Razizadeh, Mohammad Hossein, Zafarani, Alireza, Taghavi-Farahabadi, Mahsa, Khorramdelazad, Hossein, Minaeian, Sara, Mahmoudi, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519079/ https://www.ncbi.nlm.nih.gov/pubmed/37749597 http://dx.doi.org/10.1186/s12964-023-01266-2

Ejemplares similares

Natural killer cells in COVID-19: from infection, to vaccination and therapy
por: Zafarani, Alireza, et al.
Publicado: (2023)

Reason for peripheral blood natural killer cell depletion in severe COVID-19 patients
por: Razizadeh, Mohammad Hossein
Publicado: (2022)

Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes
por: Taghavi-Farahabadi, Mahsa, et al.
Publicado: (2020)

Mink is an important possible route of introducing viral respiratory infections into the human population
por: Razizadeh, Mohammad Hossein
Publicado: (2023)

Global Status of Bufavirus, Cosavirus, and Saffold Virus in Gastroenteritis: A Systematic Review and Meta-Analysis
por: Razizadeh, Mohammad Hossein, et al.
Publicado: (2022)

Bladder cancer and human papillomavirus association: a systematic review and meta-analysis
por: Khatami, Alireza, et al.
Publicado: (2022)

Pulmonary Tuberculosis Diagnosis: Where We Are?
por: Leylabadlo, Hamed Ebrahimzadeh, et al.
Publicado: (2016)

Ischemia detection by electrocardiogram in wavelet domain using entropy measure
por: Rabbani, Hossein, et al.
Publicado: (2011)

The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics
por: Abbasifard, Mitra, et al.
Publicado: (2020)

Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
por: Zhu, Liya, et al.
Publicado: (2017)

Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
por: Hatami, Zahra, et al.
Publicado: (2023)

Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
por: Khorramdelazad, Hossein, et al.
Publicado: (2021)

Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2009)

Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?
por: Duraisamy, Ganesh Selvaraj, et al.
Publicado: (2020)

Natural Products and Synthetic Biology: Where We Are and Where We Need To Go
por: Kunakom, Sylvia, et al.
Publicado: (2019)

Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
por: Kazemi, Mohammad Hossein, et al.
Publicado: (2022)

Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now?
por: Mannavola, Francesco, et al.
Publicado: (2019)

Full small molecule conversion of human fibroblasts to neuroectodermal cells via a cocktail of Dorsomorphin and Trichostatin A
por: Hosseini Farahabadi, Samaneh Sadat, et al.
Publicado: (2020)

Natural Killer Cells in Viral Hepatitis
por: Rehermann, Barbara
Publicado: (2015)

Forecasting influenza hemagglutinin mutations through the lens of anomaly detection
por: Garjani, Ali, et al.
Publicado: (2023)

Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to
por: Ojha, Probir Kumar, et al.
Publicado: (2020)

Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
por: Yousefi, Parastoo, et al.
Publicado: (2023)

Natural Products as a Potential Source of Promising Therapeutics for COVID-19 and Viral Diseases
por: Bafandeh, Soheila, et al.
Publicado: (2023)

Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer's disease
por: Vakilian, Alireza, et al.
Publicado: (2019)

Natural Killer Cells in Immunotherapy: Are We Nearly There?
por: Bachiller, Mireia, et al.
Publicado: (2020)

Chronic Viral Hepatitis in Malaysia: "Where are we now?"
por: Raihan, Ruksana, et al.
Publicado: (2017)

Therapeutic Intervention in Motor Disorders at Young and Old Age: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2001)

Animal Models for COVID-19 Therapeutic Development: Where We Are and Where We Need to Go
por: Zhao, Sihai, et al.
Publicado: (2022)

Viral Evasion of Natural Killer Cell Activation
por: Ma, Yi, et al.
Publicado: (2016)

Viral Infection of Human Natural Killer Cells
por: van Erp, Elisabeth A., et al.
Publicado: (2019)

R Peak Detection in Electrocardiogram Signal Based on an Optimal Combination of Wavelet Transform, Hilbert Transform, and Adaptive Thresholding
por: Rabbani, Hossein, et al.
Publicado: (2011)

Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy
por: Hosseini, Reza, et al.
Publicado: (2022)

Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?
por: Mianehsaz, Elaheh, et al.
Publicado: (2019)

Therapeutic Drug Monitoring of Ganciclovir: Where Are We?
por: Märtson, Anne-Grete, et al.
Publicado: (2022)

High Serum Levels of TGF-β in Iranians With Chronic HBV Infection
por: Khorramdelazad, Hossein, et al.
Publicado: (2012)

Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed
por: Qu, Tailong, et al.
Publicado: (2022)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Future perspectives on swine viral vaccines: where are we headed?
por: Opriessnig, Tanja, et al.
Publicado: (2021)

Uptake Characterization of Tumor Cell-derived Exosomes by Natural Killer Cells
por: HUYAN, Ting, et al.
Publicado: (2018)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_s8tvrfk3avu3q1ch76aua3nks4